Lab Corp. (LH) Tops Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/9/2026
- Nasdaq ends sharply higher; chip surge offsets Iran worries
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Applied Materials surges as CEO signals multi-year chip boom
- Oil prices settle 2% lower as economic worries outweigh supply risks
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- GameStop stockholders approve share count increase to 2.5 billion
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- Key things to know ahead of SK Hynix’s blockbuster US listing
- AI bubble fears mount as Zuckerberg admits agent delays and Burry shorts sector
LabCorp Announces Agreement To Acquire Sequenom
July 27, 2016 7:01 AM EDTBURLINGTON, N.C., and SAN DIEGO, July 27, 2016 /PRNewswire/ -- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH), the world's leading healthcare diagnostics company, and Sequenom, Inc. (NASDAQ: SQNM), a pioneer in non-invasive prenatal testing (NIPT) for reproductive health, today announced that they have entered into a definitive agreement and plan of merger under which LabCorp would acquire all of the outstanding shares of Sequenom in a cash tender offer for $2.40 per share, or an equity value of $302 million, which represents a total enterprise value of approximately $371 million, including net indebtedness.... More
LabCorp Announces Agreement to Acquire Sequenom
July 27, 2016 6:59 AM EDTAcquisition Creates Market Leader in NIPT, Womens Health and Reproductive Genetics
LabCorp CEO: This is exactly the kind of strategic acquisition that LabCorp seeks
BURLINGTON, N.C. & SAN DIEGO--(BUSINESS WIRE)-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH), the worlds leading healthcare diagnostics company, and Sequenom, Inc. (NASDAQ: SQNM), a pioneer in non-invasive prenatal testing (NIPT) for reproductive health, today announced that they have entered into a definitive agreement and plan of merger under... More
Laboratory Corporation of America® Holdings Announces 2016 Second Quarter Results and Raises 2016 Guidance
July 27, 2016 6:56 AM EDTQ2 Net revenue of $2.4 billion, up 7% over last year Q2 Diluted EPS of $1.91; Q2 Adjusted EPS of $2.31, up 11% over last year 2016 Adjusted EPS guidance raised to $8.60 $8.95, up 9% to 13% over 2015
BURLINGTON, N.C.--(BUSINESS WIRE)-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced results for the quarter ended June 30, 2016.
Continued strong revenue growth and double-digit adjusted EPS growth demonstrate the soundness of our strategy, said David P. King, chairman and chief executive officer. Our results reflect our customers... More
